Unknown PHASE4 INTERVENTIONAL 2-arm NCT01694459

DEDICA (Dose of HEparin During Coronary Angioplasty) Trial (DEDICA)

Comparison of Low-dose Heparin Versus Standard Dose Heparin During Coronary Interventions (DEDICA Trial)

Sponsor: San Filippo Neri General Hospital

Conditions Angina, Unstable Non-ST Elevation (NSTEMI) Myocardial Infarction Stable Angina

Interventions Low-dose heparin Standard dose heparin

Updated 5 times since 2017 Last updated: Sep 26, 2012 Started: Jan 31, 2010 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01694459, this PHASE4 trial focuses on Angina, Unstable and Non-ST Elevation (NSTEMI) Myocardial Infarction and remains ongoing. Sponsored by San Filippo Neri General Hospital, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

San Filippo Neri General Hospital
University of Roma La Sapienza

Data source: San Filippo Neri General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy